X0202 4 2004-01-01 0 0000761237 IMCOR PHARMACEUTICAL CO ICRP.PK 0001262293 WATSON ALAN ONE KENDALL SQUARE BUILDING 1000 5TH FLOOR CAMBRIDGE MA 02139 1 0 0 0 Common Stock 1250 D Options (Right to Buy) 18.6 2004-01-03 2013-01-03 Common Stock 500 500 D Options (Right to Buy) 41 2003-02-01 2013-02-03 Common Stock 500 1000 D Options (Right to Buy) 44 2003-04-01 2013-04-01 Common Stock 3000 4000 D Options (Right to Buy) 36.2 2004-01-01 4 A 0 500 36.2 A 2004-04-01 2014-01-01 Common Stock 500 4500 D Reflects one-for-twenty reverse split that was effective as of March 4, 2005. Previously reported. These options are fully vested. The Compensation Committee and the issuer's board approved grants of non-qualified options to the reporting person on the terms described in Table II. The options vest in accordance and are in other respects subject to stock option award agreements. On January 1, 2004, Mr. Watson was granted an option to acquire a total of 10,000 shares of the issuer's common stock; all of these options are vested. Mr. Watson terminated his consulting agreement with the issuer as of December 31, 2004 and the options received as a consultant terminate 90 days after the termination date. Alan D. Watson 2005-03-07